A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma
Necroptosis is a regulated form of cell necroptotic process, playing a pivotal role in tumors. In renal cell cancer (RCC), inhibiting necroptosis could promote the proliferation of tumor cells. However, the molecular mechanisms and prognosis prediction of necroptotic-process-related genes in RCC are...
Main Authors: | Jingxian Li, Xun Liu, Yuanjiong Qi, Yang Liu, E. Du, Zhihong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.922929/full |
Similar Items
-
Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
by: Cong Chen, et al.
Published: (2022-06-01) -
Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma
by: Lixia Xu, et al.
Published: (2023-03-01) -
Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
by: Xingyu Peng, et al.
Published: (2022-09-01) -
Comprehensive analysis of a homeobox family gene signature in clear cell renal cell carcinoma with regard to prognosis and immune significance
by: Di Zheng, et al.
Published: (2022-10-01) -
Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma
by: Huili Ren, et al.
Published: (2022-07-01)